Aziz Nazha MD

PubMed

• Tumor Board-Inspired Multiagent Artificial Intelligence System for Interpreting Oncology Guidelines.
  Jiasheng Wang, Kirti Arora, David M Swoboda, Aziz Nazha
  JCO Clinical Cancer Informatics. 2026-01-01
• Autonomous Analysis of Curated Patient Data Using a Large Language Model-Based Multiagent Framework.
  Jiasheng Wang, David M Swoboda, Aziz Nazha
  JCO Clinical Cancer Informatics. 2025-12-01
• 4 citations
  Artificial intelligence in hematology.
  Aziz Nazha, Olivier Elemento, Sanjay Ahuja, Barbara Lam, Moses Miles
  Blood. 2025-11-06

Journal Articles

• Mutational Landscape of myelodysplastic/myeloproliferative Neoplasm – Unclassifiable (MDS/MPN-U)  
  Aziz Nazha, Rami S Komrokji, Andrew Sochacki, Mikkael A Sekeres, Prithviraj Bose, Courtney D DiNardo, Hagop M Kantarjian, Srdan Verstovsek, Sanam Loghavi, Jaroslaw P M..., Blood
• An international data set for CMML validates prognostic scoring systems and demonstrates a need for novel prognostication strategies  
  Padron E, Garcia-Manero G, Patnaik MM, Itzykson R, Lasho T, Nazha A, Rampal RK, Sanchez ME, Jabbour E, Al Ali NH, Thompson Z, Colla S, Fenaux P, Kantarjian HM, Killick..., Blood Cancer J, 1/31/2015
• Fibrogenesis in Primary Myelofibrosis: Diagnostic, Clinical and Therapeutic Implications  
  Nazha A, Khoury JD, Rampal R, Daver N, Oncologist, 1/24/2015

Abstracts/Posters

• Epigenomic Signatures in Myelodysplastic Syndrome Patients As Predictors of Donor Compatibility and Transplant Outcome
  Aziz Nazha, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Geno-Clinical Model for the Diagnosis of Bone Marrow Myeloid Neoplasms
  Aziz Nazha, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Preliminary Results from the Phase II Study of the IDH2-Inhibitor Enasidenib in Patients with High-Risk IDH2-Mutated Myelodysplastic Syndromes (MDS)
  Aziz Nazha, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

• The Molecular Maelstrom of Myelodysplastic Syndromes (MDS) 
  60th American Society of Hematology Annual Meeting - 12/2/2018
• Genomic Biomarkers Predict Response/Resistance to Lenalidomide in Non-Del(5q) Myelodysplastic Syndromes 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Association of MHC Class I Chain-Related Gene a (MICA) Polymorphisms with Allogeneic Hematopoietic Cell Transplantation Outcomes in Acute Myeloid Leukemia 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018